These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4403714)

  • 1. [Review of literature and experimental contribution on KO 592 a drug with beta-adrenolytic activity. II].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(2):117-63. PubMed ID: 4403714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-adrenalytics and gastric, intestinal and uterine musculature. Experimental research with pronethalal, propranolol, Kö 592, MJ 1998, MJ 1999 and iproveratril].
    Marmo E; Coscia L; Magliulo S
    Farmaco Sci; 1967 Sep; 22(9):735-68. PubMed ID: 4383230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental study on the pharmacology of a beta-adrenolytic agent: H 56-28 alprenolol. Studies with a special regard to the cardiovascular system, tracheal, gastric, intestinal, splenic and deferent muscles].
    Marmo E
    Clin Ter; 1971 Jan; 56(2):121-76. PubMed ID: 4397371
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies on the question of differentiation of adrenergic beta-receptors].
    Mentz P; Bayer B; Wartner U; Förster W
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):23-9. PubMed ID: 4394699
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiation of beta-adrenoreceptors by the use of blocking agents.
    Farmer JB; Levy GP
    J Pharm Pharmacol; 1970 Feb; 22(2):145-6. PubMed ID: 4392256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonging hexabarbiturate anesthesia by beta adrenolytic drugs].
    Wagner J; Kierfeld E
    Arzneimittelforschung; 1971 Mar; 21(3):414-6. PubMed ID: 4396292
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of isoprenaline and beta-adrenoceptor blocking drugs on intestinal smooth muscle.
    Farmer JB; Levy GP
    Br J Pharmacol; 1970 Sep; 40(1):154P-155P. PubMed ID: 4395085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution to the pharmacology of the beta-adrenolytics].
    Wagner J
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2442-8. PubMed ID: 4394708
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-serotonin action of substances blocking the adrenergic beta-receptor].
    Stanislawska J; Wajszczuk-Religa A
    Acta Physiol Pol; 1970; 21(6):757-65. PubMed ID: 4395274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some pharmacological properties of four stereoisomers of butidrine, a new adrenergic beta-receptor antagonist.
    Ferrini R
    Arzneimittelforschung; 1968 Jan; 18(1):48-50. PubMed ID: 4386975
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
    Lish PM; Weikel JH; Dungan KW
    J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial reaction to adrenergic drugs during the early periods of development (review of the literature)].
    Viktorov AP
    Farmakol Toksikol; 1977; 40(2):239-45. PubMed ID: 15864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Competitive antagonism between isoprenalin and adrenolytic agents toward urease].
    Mentz P; Förster W; Barth A; Gieszler C
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):280-6. PubMed ID: 4146787
    [No Abstract]   [Full Text] [Related]  

  • 16. Chlorpromazine metabolism. VI. Adrenolytic and antiserotonergic activities of chlorpromazine and its various metabolites.
    Kaul PN; Pabrai PR; Farmer M
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):325-37. PubMed ID: 4149789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of some beta-blocking agents on the effect of bradykinin on isolated guinea pig ileum].
    Bernardi M; Bertolini A; Castelli M
    Boll Soc Ital Biol Sper; 1967 Oct; 43(19):1299-301. PubMed ID: 4385418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a beta-adrenergic block with pronethalol, propranolol, hydrobutamine, C.39'089-Ba and H 56-28 on the electrocardiographic modifications of NaCl,MgCl 2 and KCl in rat].
    Marmo E; Caputi A; Fucci G; Imperatore A
    Folia Cardiol; 1969; 28():83-91. PubMed ID: 4398000
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies of the specificity and aspecificity of a beta-adrenolytic agent, bunitrolol (Kö 1366)].
    Marmo E; Lampa E; Rossi F; Caputi AP; Chieppa S; Vacca C; Giordano L; Pedone P
    Arch Sci Med (Torino); 1978; 135(1):15-56. PubMed ID: 25057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.